Hsbc Holdings PLC Amneal Pharmaceuticals, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 60,061 shares of AMRX stock, worth $503,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,061
Previous 46,304
29.71%
Holding current value
$503,311
Previous $385,000
23.38%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$124 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$75.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...